CSIMarket
 


Nanostring Technologies Inc   (NSTG)
Other Ticker:  
 
 

Nanostring Technologies Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Nanostring Technologies Inc 's ability to collect accounts receivable sequentially worsen to 4.12, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Nanostring Technologies Inc 's Average receivable collection period in the Sep 30 2023 quarter, has increased to 89 days, from 87 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 244 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1962, from overall ranking in the second quarter 2023 at 2287.

What is Receivable Turnover Ratio?
What is Nanostring Technologies Inc Selling?


What is Receivable Turnover Ratio?




NSTG Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change 77.29 % 36.87 % 14.77 % -21.49 % -23.11 %
Y / Y Revenue Change 62.79 % 37.05 % 15.2 % -18.92 % -20.48 %
Receivable Turnover Ratio (TTM) 4.12 4.21 4.22 4.22 4.19
NSTG's Total Ranking # 1962 # 2287 # 2457 # 2452 # 1376
Average receivable collection period 89 87 86 86 87
Seq. Receivable Change 12.49 % 23.27 % 10.67 % 15.52 % -13.15 %
Seq. Revenue Change 8.9 % 23.33 % 4.02 % 16.52 % -8.31 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 245
Overall Market # 1962

Receivable Turnover Ratio Statistics
High Average Low
0.96 0.56 0.28
(Sep 30 2018)   (Jun 30 2021)






Financial Statements
Nanostring Technologies Inc 's Accounts Receivable $ 48 Millions Visit NSTG's Balance sheet
Nanostring Technologies Inc 's Sales TTM $ 162 Millions Visit NSTG's Income Statement
Where are NSTG's Sales coming from? Visit NSTG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NSTG's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for NSTG's Competitors
Receivables Turnover Ratio for NSTG's Suppliers
Accounts Receivables Turnover Ratio for NSTG's Customers

You may also want to know
NSTG's Growth Rates NSTG's Roa NSTG's Inventory Turnover Ratio NSTG's Dividend Comparisons
NSTG's Profitability Ratios NSTG's Roi NSTG's Asset Turnover Ratio NSTG's Dividend Growth
NSTG's Valuation Ratios NSTG's Roe NSTG's Financial Strength Ratios NSTG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Cara Therapeutics inc   9.20 $ 21.225  Millions$ 2.308  Millions
Acorda Therapeutics Inc   9.18 $ 111.118  Millions$ 12.106  Millions
Harmony Biosciences Holdings inc   9.09 $ 541.622  Millions$ 59.598  Millions
Myomo Inc   9.08 $ 17.258  Millions$ 1.901  Millions
Talis Biomedical Corporation  9.04 $ 2.196  Millions$ 0.243  Millions
Avid Bioservices Inc   8.95 $ 140.252  Millions$ 15.678  Millions
Emmaus Life Sciences Inc   8.94 $ 28.460  Millions$ 3.185  Millions
Inspire Medical Systems inc   8.90 $ 569.809  Millions$ 63.989  Millions
Biodesix Inc   8.87 $ 44.026  Millions$ 4.966  Millions
Sanara Medtech Inc   8.83 $ 61.677  Millions$ 6.987  Millions
Insmed Inc  8.76 $ 277.639  Millions$ 31.691  Millions
Arrowhead Pharmaceuticals Inc   8.73 $ 240.735  Millions$ 27.562  Millions
Arcturus Therapeutics Holdings Inc   8.70 $ 296.237  Millions$ 34.067  Millions
Immucell Corp  8.69 $ 15.668  Millions$ 1.803  Millions
Addus Homecare Corporation  8.64 $ 1,028.360  Millions$ 119.077  Millions
Adapthealth Corp   8.62 $ 3,122.226  Millions$ 362.205  Millions
Celldex Therapeutics inc   8.60 $ 4.365  Millions$ 0.508  Millions
Zymeworks Inc   8.53 $ 461.579  Millions$ 54.102  Millions
Henry Schein Inc  8.53 $ 12,693.000  Millions$ 1,488.250  Millions
Acadia Healthcare Company Inc   8.49 $ 2,923.743  Millions$ 344.337  Millions
Adma Biologics Inc   8.48 $ 233.238  Millions$ 27.518  Millions
Lensar Inc   8.47 $ 40.291  Millions$ 4.758  Millions
Clearpoint Neuro Inc   8.45 $ 22.319  Millions$ 2.642  Millions
Lumos Pharma Inc   8.39 $ 1.737  Millions$ 0.207  Millions
Avita Medical Inc   8.37 $ 45.403  Millions$ 5.426  Millions
Silk Road Medical Inc   8.36 $ 169.880  Millions$ 20.317  Millions
Harrow Inc   8.29 $ 114.100  Millions$ 13.772  Millions
Ati Physical Therapy Inc   8.26 $ 678.488  Millions$ 82.158  Millions
Pulmatrix Inc   8.25 $ 6.804  Millions$ 0.824  Millions
Repare Therapeutics Inc   8.21 $ 56.692  Millions$ 6.907  Millions

Date modified: 2023-11-07T12:35:48+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com